Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Factors for Failure of Erythema Migrans Treatment - Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Adult Patients With Erythema Migrans: Clinical and Microbiological Outcome.

NCT01518192 is registered in ClinicalTrials.gov with University Medical Centre Ljubljana as lead sponsor.

NCT NCT01518192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01518192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Factors for Failure of Erythema Migrans Treatment - Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Adult Patients With Erythema Migrans: Clinical and Microbiological Outcome.
Lead sponsor
University Medical Centre Ljubljana
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2006
Completion date
January 31, 2009
Enrollment
544 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

erythema migrans, post-lyme disease symptoms